# Timing of ctDNA Testing in Advanced Breast Cancer

> **NCT07681323** · — · RECRUITING · sponsor: **Geneplus-Beijing Co. Ltd.** · enrollment: 400 (estimated)

## Conditions studied

- Advanced Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07681323
- **Lead sponsor:** Geneplus-Beijing Co. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-08
- **Primary completion:** 2027-06-30
- **Final completion:** 2029-06-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07681323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07681323, "Timing of ctDNA Testing in Advanced Breast Cancer". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07681323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*